NEWS

April 30, 2021

ResMed swings to loss after tax dispute provision

MELBOURNE: Sleep apnoea treatments maker ResMed has recorded a quarterly loss after sales ... read more

April 30, 2021

Mesoblast holds out hope for COVID project says CEO

MELBOURNE: Mesoblast is not giving up on its COVID-19 treatment despite ending its ... read more

April 30, 2021

PainChek delivers another quarter of growth says CEO

PERTH: Over the March 2021 quarter, PainChek (PCK) expanded sales in Australia as ... read more

April 30, 2021

InteliCare secures $2.5m to fund commercialisation strategy

PERTH: Perth-based InteliCare Holdings (ASX:ICR) is well-funded to execute the next stage of ... read more